The scientific community and the impact of the Myriad Genetics Supreme Court decision
The Scientist
Most Recent
The researchers who first identified a novel coronavirus say they have shared the virus freely.
The justices unanimously upheld Monsanto’s patent rights on Roundup Ready seeds.
A decision will not be reached until later in the year, but the United States’ top justices appear to be inclined to rule against the validity of patenting human genes.
2012 saw the birth of a handful of non-invasive genetic prenatal tests, but the young industry faces growing pains as legal and ethical questions loom.
After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.
As the United States edges ever closer to the dreaded fiscal cliff, the pharmaceutical industry approaches a precipice of its own.
Three patents on transgenic apes in the European Union will be challenged by animal rights activists.
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Patent expirations of one HIV drugs will make the disease cheaper—but also more cumbersome—to treat.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
